Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.

Santoro AB, Struchiner CJ, Suarez-Kurtz G.

Br J Clin Pharmacol. 2016 Aug 16. doi: 10.1111/bcp.13064. [Epub ahead of print] No abstract available.

PMID:
27527610
2.

Limited sampling strategy for determining metformin area under the plasma concentration-time curve.

Santoro AB, Stage TB, Struchiner CJ, Christensen MM, Brosen K, Suarez-Kurtz G.

Br J Clin Pharmacol. 2016 Jun 20. doi: 10.1111/bcp.13049. [Epub ahead of print]

PMID:
27324407
3.

A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I.

de Melo AC, Grazziotin-Reisner R, Erlich F, Fontes Dias MS, Moralez G, Carneiro M, Ingles Garces ÁH, Guerra Alves FV, Novaes Neto B, Fuchshuber-Moraes M, Morando J, Suarez-Kurtz G, Ferreira CG.

Cancer Chemother Pharmacol. 2016 Jul;78(1):101-9. doi: 10.1007/s00280-016-3064-0. Epub 2016 May 20.

PMID:
27206639
4.

Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups.

Suarez-Kurtz G, Fuchshuber-Moraes M, Struchiner CJ, Parra EJ.

Pharmacogenet Genomics. 2016 Aug;26(8):363-9. doi: 10.1097/FPC.0000000000000225.

PMID:
27136043
5.

Genome-wide association study of warfarin maintenance dose in a Brazilian sample.

Parra EJ, Botton MR, Perini JA, Krithika S, Bourgeois S, Johnson TA, Tsunoda T, Pirmohamed M, Wadelius M, Limdi NA, Cavallari LH, Burmester JK, Rettie AE, Klein TE, Johnson JA, Hutz MH, Suarez-Kurtz G.

Pharmacogenomics. 2015;16(11):1253-63. doi: 10.2217/PGS.15.73. Epub 2015 Aug 12.

6.

Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients.

Lanchote VL, Almeida R, Barral A, Barral-Netto M, Marques MP, Moraes NV, da Silva AM, Souza TM, Suarez-Kurtz G.

Br J Clin Pharmacol. 2015 Nov;80(5):1160-8. doi: 10.1111/bcp.12677. Epub 2015 Jul 2.

PMID:
25940755
7.

Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.

Bonifaz-Peña V, Contreras AV, Struchiner CJ, Roela RA, Furuya-Mazzotti TK, Chammas R, Rangel-Escareño C, Uribe-Figueroa L, Gómez-Vázquez MJ, McLeod HL, Hidalgo-Miranda A, Parra EJ, Fernández-López JC, Suarez-Kurtz G.

PLoS One. 2014 Nov 24;9(11):e112640. doi: 10.1371/journal.pone.0112640. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122161.

8.

Pharmacogenetics of coumarin anticoagulants in Brazilians.

Suarez-Kurtz G, Botton MR.

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):67-79. doi: 10.1517/17425255.2015.976201. Epub 2014 Oct 25. Review.

PMID:
25345887
9.

Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.

Friedrich DC, Genro JP, Sortica VA, Suarez-Kurtz G, de Moraes ME, Pena SD, dos Santos AK, Romano-Silva MA, Hutz MH.

PLoS One. 2014 Oct 20;9(10):e110691. doi: 10.1371/journal.pone.0110691. eCollection 2014.

10.

Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of oxicam NSAIDs.

Suarez-Kurtz G.

Pharmacogenet Genomics. 2014 Aug;24(8):406-7. doi: 10.1097/FPC.0000000000000064. No abstract available.

PMID:
25003537
11.

Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.

Santoro AB, Vargens DD, Barros Filho Mde C, Bulzico DA, Kowalski LP, Meirelles RM, Paula DP, Neves RR, Pessoa CN, Struchine CJ, Suarez-Kurtz G.

Br J Clin Pharmacol. 2014 Nov;78(5):1067-75. doi: 10.1111/bcp.12437.

12.

Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.

Carvalho RS, Abreu RB, Velkova A, Marsillac S, Rodarte RS, Suarez-Kurtz G, Iversen ES, Monteiro AN, Carvalho MA.

PLoS One. 2014 May 20;9(5):e97766. doi: 10.1371/journal.pone.0097766. eCollection 2014.

13.

Characterization of LGALS3 (galectin-3) as a player in DNA damage response.

Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA.

Cancer Biol Ther. 2014 Jul;15(7):840-50. doi: 10.4161/cbt.28873. Epub 2014 Apr 22.

14.

Clinically actionable genotypes among Brazilians.

Suarez-Kurtz G.

Clin Pharmacol Ther. 2014 Jul;96(1):25-6. doi: 10.1038/clpt.2014.56. Epub 2014 Mar 5. No abstract available.

PMID:
24598719
15.

Demographic history and human genetic diversity: pharmacogenomic implications.

Parra EJ, Suarez-Kurtz G.

Pharmacogenomics. 2014 Feb;15(3):253-6. doi: 10.2217/pgs.14.10. No abstract available.

16.

Pharmacogenomic implications of population admixture: Brazil as a model case.

Suarez-Kurtz G, Paula DP, Struchiner CJ.

Pharmacogenomics. 2014 Feb;15(2):209-19. doi: 10.2217/pgs.13.238. Review.

PMID:
24444410
17.

Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.

Suarez-Kurtz G, Vargens DD, Santoro AB, Hutz MH, de Moraes ME, Pena SD, Ribeiro-dos-Santos Â, Romano-Silva MA, Struchiner CJ.

PLoS One. 2014 Jan 10;9(1):e83472. doi: 10.1371/journal.pone.0083472. eCollection 2014.

18.

Association of genetic variants with self-assessed color categories in Brazilians.

Durso DF, Bydlowski SP, Hutz MH, Suarez-Kurtz G, Magalhães TR, Pena SD.

PLoS One. 2014 Jan 8;9(1):e83926. doi: 10.1371/journal.pone.0083926. eCollection 2014.

19.

CYP3A5 genotype, but not CYP3A4*1b, CYP3A4*22, or hematocrit, predicts tacrolimus dose requirements in Brazilian renal transplant patients.

Santoro AB, Struchiner CJ, Felipe CR, Tedesco-Silva H, Medina-Pestana JO, Suarez-Kurtz G.

Clin Pharmacol Ther. 2013 Aug;94(2):201-2. doi: 10.1038/clpt.2013.68. Epub 2013 Apr 2. No abstract available.

PMID:
23588314
20.

Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin.

Botton MR, Hutz MH, Suarez-Kurtz G.

Pharmacogenomics. 2012 Nov;13(14):1557-9; author reply 1561-2. doi: 10.2217/pgs.12.151.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk